Handelsbanken Fonder AB - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 67 filers reported holding AMRYT PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q1 2023$7,657
-26.0%
525,178
-62.9%
0.04%
-32.3%
Q4 2022$10,342
-99.9%
1,416,646
+3.0%
0.06%
+1.6%
Q3 2022$9,519,000
-1.0%
1,375,6010.0%0.06%
+3.2%
Q2 2022$9,615,000
-11.5%
1,375,601
+4.6%
0.06%
+1.6%
Q1 2022$10,867,0001,315,6010.06%
Other shareholders
AMRYT PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,292,00022.96%
Stonepine Capital Management, LLC 6,227,733$43,096,00019.37%
MPM ASSET MANAGEMENT LLC 2,668,843$18,468,0007.03%
Aquilo Capital Management, LLC 1,998,993$13,833,0004.99%
New Leaf Venture Partners, L.L.C. 449,737$3,112,0001.85%
Global Frontier Investments LLC 505,000$3,495,0001.77%
Rubric Capital Management LP 3,600,000$24,912,0001.26%
Telemetry Investments, L.L.C. 123,000$851,0001.09%
Nantahala Capital Management 1,437,458$9,947,0000.64%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$43,828,0000.62%
View complete list of AMRYT PHARMA PLC shareholders